Hand-Foot Syndrome: Highlighting Adverse Effect Management and Patient Education in the Age of Multikinase Inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hand-Foot Syndrome: Highlighting Adverse Effect Management and Patient Education in the Age of Multikinase Inhibitors

Published:2024-09-01 Issue:9 Volume:36 Page:338-341
ISSN:2329-9711
Container-title:Clinical Thyroidology®
language:en
Short-container-title:Clinical Thyroidology®

Author:

McNeil James¹²,Gild Matti L.¹³,Tsang Venessa H.¹³

Affiliation:

1. Department of Diabetes, Endocrinology & Metabolism, Royal North Shore Hospital Sydney, New South Wales, Australia

2. Department of Nuclear Medicine, PET and Bone Densitometry, Royal Adelaide Hospital, South Australia, Australia

3. Faculty of Medicine and Health Sciences, University of Sydney, Sydney, New South Wales, Australia

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/ct.2024%3B36.338-341

Reference9 articles.

1. Hand-foot skin reaction with vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: A systematic review and meta-analysis

2. A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours

3. Hand–foot syndrome in sorafenib and lenvatinib treatment for advanced thyroid cancer

4. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

5. Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP